Skip to main content
logo
LIR Life Sciences Corp. (CSE:SKNY)
Canada flag Canada · Delayed Price · Currency is CAD
0.1800
-0.0200 (-10.00%)
At close: Sep 18, 2026

LIR Life Sciences Balance Sheet

Millions CAD. Fiscal year is May - Apr.

Assets

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Apr '26 Apr '25 Apr '24
Cash & Equivalents
0.60.120.2
Cash & Short-Term Investments
0.60.120.2
Cash Growth
393.49%-38.01%-
Other Receivables
0.07-0.01
Receivables
0.07-0.01
Prepaid Expenses
0.17--
Total Current Assets
0.840.120.2
Total Assets
0.840.120.2

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Apr '26 Apr '25 Apr '24
Accounts Payable
0.110.20.04
Accrued Expenses
0.07--
Short-Term Debt
--0.19
Total Current Liabilities
0.180.20.23
Total Liabilities
0.180.20.23

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Apr '26 Apr '25 Apr '24
Common Stock
4.070.30
Retained Earnings
-4.35-0.45-0.03
Comprehensive Income & Other
0.940.07-
Shareholders' Equity
0.66-0.08-0.03
Total Liabilities & Equity
0.840.120.2

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Apr '26 Apr '25 Apr '24
Total Debt
--0.19
Net Cash (Debt)
0.60.120
Net Cash Growth
393.49%147336.58%-
Net Cash Per Share
0.030.020.01
Filing Date Shares Outstanding
28.6718.950.01
Total Common Shares Outstanding
28.67190.01
Working Capital
0.66-0.08-0.03
Book Value Per Share
0.02-0.00-2.11
Tangible Book Value
0.66-0.08-0.03
Tangible Book Value Per Share
0.02-0.00-2.11